Aurobindo Pharma Limited, an India-based pharmaceutical company, announced the appointment of T. Vijaya Kumar as President – R&D (Specialty Drug Delivery), with effect from April 5, 2024.
According to the company’s exchange filing, “Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby inform that upon recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has appointed Mr. T. Vijaya Kumar as President – R&D (Specialty Drug Delivery) effective April 5, 2024.”
T. Vijaya Kumar holds M. Pharm. (Masters in Pharmacy) Post-Graduation in Pharmacy from Gulbarga University, Gulbarga (India) with specialization in Pharmaceutical Technology. He has around 30 years’ experience in Pharma industry. He Received prestigious Global Desh Bandhu Gupta Spirit of Lupin Award 2022 for the Value – “Passion for Excellence.”
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.